AbCellera
continued focus on high value programs and strategic partnerships with our differentiated technology position in liquidity we have a long cash runway for focused investment execution completion of engine over the next years we will continue to invest in the final stage of our engine including construction commissioning of our manufacturing facility our portfolio of partnered in we anticipate partnership deals from our cell engager platform our partnership strategy is to select high value not deal volume our portfolio of internal we expect to enter clinical development in in we expect additional first in class development candidates from our ion channel platform | AbCellera
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
13 of 14
Related slides by other companies
Kalera
Results
August 2022
us foods strategic partnership to accelerate revenue growth and a customer centric approach | Kalera
Affirm
Results
May 2023
platform portfolio and funding mix | Affirm
D-Wave
SPAC
February 2022
wave at a glance | D-Wave
Genetron
Results
June 2022
in drug development services for i a | Genetron
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Results
November 2023
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io